CVE-2026-90505vvbbnn00 WARP-Clash-API doUpdateLicenseKey race condition
Updated under an hour ago ()
Does this affect you?
It affects vvbbnn00 WARP-Clash-API. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
A vulnerability was found in vvbbnn00 WARP-Clash-API up to c7bf2360073959861219b422e51ae86411051b46. This affects the function doUpdateLicenseKey. The manipulation results in race condition. The attack can be launched remotely. The attack requires a high level of complexity. The exploitability is reported as difficult. The exploit has been made public and could be used. This product does not use versioning. This is why information about affected and unaffected releases are unavailable. The vendor was contacted early about this disclosure but did not respond in any way. This vulnerability only affects products that are no longer supported by the maintainer.
- CVSS
- 5.0 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:L/A:L/E:P/RL:X/RC:R
- Weakness (CWE)
- CWE-362
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- VulDB
- NVD analysis
- Deferred
- Record last updated
- Sep 14, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
vvbbnn00 WARP-Clash-API vvbbnn00:warp-clash-api | c7bf2360073959861219b422e51ae86411051b46 | CNA record |
References
- https://vuldb.com/vuln/403093vdb-entry, technical-description
- https://vuldb.com/vuln/403093/ctisignature, permissions-required
- https://vuldb.com/cve/CVE-2026-90505third-party-advisory
- https://vuldb.com/submit/895264third-party-advisory
- https://gist.github.com/Galaxync/62748fe998dd8518691e11d765224093exploit
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.